Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mouse gut metagenome

ABSTRACT: Mus musculus intestinal transcriptome and microbiome in diet-induced obesity

PROVIDER: PRJNA320922 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR3490420.fastq.gz	Fastqsanger.gz
	SRR3490421.fastq.gz	Fastqsanger.gz
	SRR3490402.fastq.gz	Fastqsanger.gz
	SRR3490412.fastq.gz	Fastqsanger.gz
	SRR3490422.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 186

Similar Datasets

mouse gut metagenome

Project description:Mus musculus intestinal transcriptome and microbiome in diet-induced obesity

| PRJNA551783 | ENA

mouse gut metagenome

Project description:FK506 binding protein 5 deficiency regulates gut microbiome against diet-induced obesity in mice

| PRJNA610239 | ENA

gut metagenome

Project description:QQ Diet-Induced Obesity

| PRJNA918340 | ENA

mouse gut metagenome

Project description:Interaction of gut microbiota and anti-obesity drugs in diet induced obesity model

| PRJDB12833 | ENA

mouse gut metagenome

Project description:High-fat diet-mediated dysbiosis promotes intestinal carcinogenesis independent of obesity

| PRJNA242565 | ENA

Directed Remodeling of the Mouse Gut Microbiome Inhibits the Development of Atherosclerosis [mouse tissue]

Project description:The gut microbiome is a malleable microbial community that can remodel in response to various factors, including diet, and contribute to the development of several chronic diseases, including atherosclerosis. We devised an in vitro screening protocol of the mouse gut microbiome to discover molecules that can selectively modify bacterial growth. This approach was used to identify cyclic D,L-α-peptides that remodeled the Western diet (WD) gut microbiome toward the low-fat-diet microbiome state. Daily oral administration of the peptides in WD-fed LDLr-/- mice reduced plasma total cholesterol levels and atherosclerotic plaques. Depletion of the microbiome with antibiotics abrogated these effects. Peptide treatment reprogrammed the microbiome transcriptome, suppressed the production of pro-inflammatory cytokines (including interleukin-6, tumor necrosis factor-α and interleukin-1β), rebalanced levels of short-chain fatty acids and bile acids, improved gut barrier integrity and increased intestinal T regulatory cells. Directed chemical manipulation provides an additional tool for deciphering the chemical biology of the gut microbiome and might advance microbiome-targeted therapeutics.

2019-12-31 | GSE104914 | GEO

mouse gut metagenome

Project description:Mus musculus

| PRJNA889990 | ENA

mouse gut metagenome

Project description:mus musculus

| PRJNA1020982 | ENA

Directed Remodeling of the Mouse Gut Microbiome Inhibits the Development of Atherosclerosis [bacteria]

2019-12-31 | GSE104913 | GEO

mouse gut metagenome

Project description:Mus musculus Metagenome

| PRJNA211468 | ENA